Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Covington
Chinese Patent Office
Merck
Colorcon

Generated: August 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,324,225

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,324,225
Title:Pyrrolopyrimidine compounds and their uses
Abstract: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of diseases, particularly pyrrolopyrimidine compounds and derivatives are described which inhibit protein kinases. The organic compounds are useful in treating proliferative disease.
Inventor(s): Brain; Christopher Thomas (Cambridge, MA), Sung; Moo Je (Belmont, MA), Thoma; Gebhard (Lorrach, DE)
Assignee: Novartis AG (Basel, CH) Astex Therapeutics Limited (Cambridge, GB)
Application Number:12/302,223
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 8,324,225

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Novartis Pharms Corp KISQALI FEMARA CO-PACK (COPACKAGED) letrozole; ribociclib succinate TABLET, TABLET;ORAL 209935-001 May 4, 2017 RX Yes Yes   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
Novartis Pharms Corp KISQALI ribociclib succinate TABLET;ORAL 209092-001 Mar 13, 2017 RX Yes Yes   Try a Free Trial   Try a Free Trial Y Y   Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,324,225

PCT Information
PCT FiledMay 24, 2007PCT Application Number:PCT/US2007/069595
PCT Publication Date:December 06, 2007PCT Publication Number: WO2007/140222

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Express Scripts
Fish and Richardson
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.